---
title: "YADEA: Deloitte appointed as the new auditor"
description: "According to the announcement from YADEA, based on the recommendations of the audit committee, Deloitte has been appointed as the new auditor of the company, effective from September 22, 2025, to fill"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258329836.md"
published_at: "2025-09-22T10:39:05.000Z"
---

# YADEA: Deloitte appointed as the new auditor

> According to the announcement from YADEA, based on the recommendations of the audit committee, Deloitte has been appointed as the new auditor of the company, effective from September 22, 2025, to fill the temporary vacancy left by the resignation of PricewaterhouseCoopers, and will serve until the conclusion of the next annual general meeting of the company's shareholders

According to the announcement from Yadea (01585), Deloitte has been appointed as the new auditor of the company based on the recommendations of the audit committee, effective from September 22, 2025, to fill the temporary vacancy left by the resignation of PricewaterhouseCoopers, and will serve until the conclusion of the next annual general meeting of the company's shareholders

### Related Stocks

- [01585.HK - YADEA](https://longbridge.com/en/quote/01585.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Yadea Group Holdings Ltd. (1585) Gets a Buy from Huatai Securities | Huatai Securities analyst maintained a Buy rating on Yadea Group Holdings Ltd. yesterday and set a price target of HK$18 | [Link](https://longbridge.com/en/news/271879979.md) |
| Yadea Group Holdings Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025 | Yadea Group Holdings Ltd. provided consolidated earnings guidance for the year ended 31 December 2025. For the period, t | [Link](https://longbridge.com/en/news/271638796.md) |
| Novautek Technologies expects loss of HK$30.5 million for HY | Novautek Technologies expects loss of HK$30.5 million for HY | [Link](https://longbridge.com/en/news/275923659.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| Sino Harbour Chairman Boosts Stake with Open-Market Share Purchase | Sino Harbour Holdings Group Limited's chairman, Wong Lam Ping, has increased his stake by purchasing 8,644,000 shares at | [Link](https://longbridge.com/en/news/275769398.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.